Featured Content Case and Commentary Apr 2025 ¿Cómo deberían proteger los miembros del equipo de cirugía a los pacientes que están privados de libertad de la vigilancia o intrusión de los oficiales del centro penitenciario? Anna Lin, MD and Mallory Williams, MD, MPH Case and Commentary Feb 2025 ¿Cómo se debe describir y tratar el dolor causado por la colocación del DIU? Veronica Hutchison, MD and Eve Espey, MD, MPH Articles From the Editor Jul 2021 Invisible Illness and Measurability Jennifer Dobson, MD A patient can appear healthy, but her joint pain and fatigue is diagnosable by a clinician listening closely enough to take her seriously. AMA J Ethics. 2021;23(7):E512-513. doi: 10.1001/amajethics.2021.512. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Art of Medicine Jul 2021 Imaging, Visibility, and Rendering My Body to My Self MacKenzie Davis The BRAINEATERS series consider an artist’s experiences of diagnosis, routine surveillance, and ongoing reorientation to her future. AMA J Ethics. 2021;23(7):E576-579. doi: 10.1001/amajethics.2021.576. Art of Medicine Jul 2021 Three Things to Learn and Do in Practice With Patients With Disabilities Jessica Delli Carpini Clinicians can practice disability humility by developing social understandings of disability. AMA J Ethics. 2021;23(7):E584-585. doi: 10.1001/amajethics.2021.584. Personal Narrative Jul 2021 The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19 Dorothy Wall, MA Overly physicalist approaches to caring for patients are not likely to help them. AMA J Ethics. 2021;23(7):E590-595. doi: 10.1001/amajethics.2021.590. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. Medicine and Society Jul 2021 When Disability Is Defined by Behavior, Outcome Measures Should Not Promote “Passing” Ari Ne’eman Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing. AMA J Ethics. 2021;23(7):E569-575. doi: 10.1001/amajethics.2021.569. Pagination First page « First Previous page ‹ Prev … Page 56 Page 57 Page 58 Page 59 Current page 60 Page 61 Page 62 Page 63 Page 64 … Next page Next › Last page Last »
Case and Commentary Apr 2025 ¿Cómo deberían proteger los miembros del equipo de cirugía a los pacientes que están privados de libertad de la vigilancia o intrusión de los oficiales del centro penitenciario? Anna Lin, MD and Mallory Williams, MD, MPH
Case and Commentary Feb 2025 ¿Cómo se debe describir y tratar el dolor causado por la colocación del DIU? Veronica Hutchison, MD and Eve Espey, MD, MPH
From the Editor Jul 2021 Invisible Illness and Measurability Jennifer Dobson, MD A patient can appear healthy, but her joint pain and fatigue is diagnosable by a clinician listening closely enough to take her seriously. AMA J Ethics. 2021;23(7):E512-513. doi: 10.1001/amajethics.2021.512.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Art of Medicine Jul 2021 Imaging, Visibility, and Rendering My Body to My Self MacKenzie Davis The BRAINEATERS series consider an artist’s experiences of diagnosis, routine surveillance, and ongoing reorientation to her future. AMA J Ethics. 2021;23(7):E576-579. doi: 10.1001/amajethics.2021.576.
Art of Medicine Jul 2021 Three Things to Learn and Do in Practice With Patients With Disabilities Jessica Delli Carpini Clinicians can practice disability humility by developing social understandings of disability. AMA J Ethics. 2021;23(7):E584-585. doi: 10.1001/amajethics.2021.584.
Personal Narrative Jul 2021 The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19 Dorothy Wall, MA Overly physicalist approaches to caring for patients are not likely to help them. AMA J Ethics. 2021;23(7):E590-595. doi: 10.1001/amajethics.2021.590.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
Medicine and Society Jul 2021 When Disability Is Defined by Behavior, Outcome Measures Should Not Promote “Passing” Ari Ne’eman Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing. AMA J Ethics. 2021;23(7):E569-575. doi: 10.1001/amajethics.2021.569.
